301 related articles for article (PubMed ID: 19966300)
1. Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation.
Hydbring P; Bahram F; Su Y; Tronnersjö S; Högstrand K; von der Lehr N; Sharifi HR; Lilischkis R; Hein N; Wu S; Vervoorts J; Henriksson M; Grandien A; Lüscher B; Larsson LG
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):58-63. PubMed ID: 19966300
[TBL] [Abstract][Full Text] [Related]
2. Myc, Cdk2 and cellular senescence: Old players, new game.
Campaner S; Doni M; Verrecchia A; Fagà G; Bianchi L; Amati B
Cell Cycle; 2010 Sep; 9(18):3655-61. PubMed ID: 20818171
[TBL] [Abstract][Full Text] [Related]
3. Cdk2: a key regulator of the senescence control function of Myc.
Hydbring P; Larsson LG
Aging (Albany NY); 2010 Apr; 2(4):244-50. PubMed ID: 20445224
[TBL] [Abstract][Full Text] [Related]
4. Tipping the balance: Cdk2 enables Myc to suppress senescence.
Hydbring P; Larsson LG
Cancer Res; 2010 Sep; 70(17):6687-91. PubMed ID: 20713526
[TBL] [Abstract][Full Text] [Related]
5. Cdk2 deficiency decreases ras/CDK4-dependent malignant progression, but not myc-induced tumorigenesis.
Macias E; Kim Y; Miliani de Marval PL; Klein-Szanto A; Rodriguez-Puebla ML
Cancer Res; 2007 Oct; 67(20):9713-20. PubMed ID: 17942901
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological inactivation of CDK2 inhibits MYC/BCL-XL-driven leukemia in vivo through induction of cellular senescence.
Bazzar W; Bocci M; Hejll E; Högqvist Tabor V; Hydbring P; Grandien A; Alzrigat M; Larsson LG
Cell Cycle; 2021 Jan; 20(1):23-38. PubMed ID: 33356836
[TBL] [Abstract][Full Text] [Related]
7. Interferon-γ-induced p27KIP1 binds to and targets MYC for proteasome-mediated degradation.
Bahram F; Hydbring P; Tronnersjö S; Zakaria SM; Frings O; Fahlén S; Nilsson H; Goodwin J; von der Lehr N; Su Y; Lüscher B; Castell A; Larsson LG
Oncotarget; 2016 Jan; 7(3):2837-54. PubMed ID: 26701207
[TBL] [Abstract][Full Text] [Related]
8. Constitutive CCND1/CDK2 activity substitutes for p53 loss, or MYC or oncogenic RAS expression in the transformation of human mammary epithelial cells.
Junk DJ; Cipriano R; Stampfer M; Jackson MW
PLoS One; 2013; 8(2):e53776. PubMed ID: 23390492
[TBL] [Abstract][Full Text] [Related]
9. MYC and RAS are unable to cooperate in overcoming cellular senescence and apoptosis in normal human fibroblasts.
Zhang F; Zakaria SM; Högqvist Tabor V; Singh M; Tronnersjö S; Goodwin J; Selivanova G; Bartek J; Castell A; Larsson LG
Cell Cycle; 2018; 17(24):2697-2715. PubMed ID: 30526305
[TBL] [Abstract][Full Text] [Related]
10. MYC can enforce cell cycle transit from G1 to S and G2 to S, but not mitotic cellular division, independent of p27-mediated inihibition of cyclin E/CDK2.
Deb-Basu D; Karlsson A; Li Q; Dang CV; Felsher DW
Cell Cycle; 2006 Jun; 5(12):1348-55. PubMed ID: 16760657
[TBL] [Abstract][Full Text] [Related]
11. p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2.
Chu I; Sun J; Arnaout A; Kahn H; Hanna W; Narod S; Sun P; Tan CK; Hengst L; Slingerland J
Cell; 2007 Jan; 128(2):281-94. PubMed ID: 17254967
[TBL] [Abstract][Full Text] [Related]
12. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts.
Stein GH; Drullinger LF; Soulard A; Dulić V
Mol Cell Biol; 1999 Mar; 19(3):2109-17. PubMed ID: 10022898
[TBL] [Abstract][Full Text] [Related]
13. Cdk2 suppresses cellular senescence induced by the c-myc oncogene.
Campaner S; Doni M; Hydbring P; Verrecchia A; Bianchi L; Sardella D; Schleker T; Perna D; Tronnersjö S; Murga M; Fernandez-Capetillo O; Barbacid M; Larsson LG; Amati B
Nat Cell Biol; 2010 Jan; 12(1):54-9; sup pp 1-14. PubMed ID: 20010815
[TBL] [Abstract][Full Text] [Related]
14. Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells.
Kang J; Sergio CM; Sutherland RL; Musgrove EA
BMC Cancer; 2014 Jan; 14():32. PubMed ID: 24444383
[TBL] [Abstract][Full Text] [Related]
15. AP4 directly downregulates p16 and p21 to suppress senescence and mediate transformation.
Jackstadt R; Jung P; Hermeking H
Cell Death Dis; 2013 Aug; 4(8):e775. PubMed ID: 23949224
[TBL] [Abstract][Full Text] [Related]
16. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc.
Vlach J; Hennecke S; Alevizopoulos K; Conti D; Amati B
EMBO J; 1996 Dec; 15(23):6595-604. PubMed ID: 8978686
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.
Carroll JS; Swarbrick A; Musgrove EA; Sutherland RL
Cancer Res; 2002 Jun; 62(11):3126-31. PubMed ID: 12036924
[TBL] [Abstract][Full Text] [Related]
18. Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc.
Caldon CE; Sergio CM; Schütte J; Boersma MN; Sutherland RL; Carroll JS; Musgrove EA
Mol Cell Biol; 2009 Sep; 29(17):4623-39. PubMed ID: 19564413
[TBL] [Abstract][Full Text] [Related]
19. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
[TBL] [Abstract][Full Text] [Related]
20. c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry.
Prall OW; Rogan EM; Musgrove EA; Watts CK; Sutherland RL
Mol Cell Biol; 1998 Aug; 18(8):4499-508. PubMed ID: 9671459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
